Clinical spectrum and treatment responses in
- 18 April 2026
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (5) , 438
Abstract
No abstract availableKeywords
Funding Information
- CQMU Program for Youth Innovation in Future Medicine (No.W0121)
This publication has 54 references indexed in Scilit:
- The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research settingHuman Genetics, 2020
- Different experiences of two PRRT2-associated self-limited familial infantile epilepsyActa Neurologica Belgica, 2020
- Novel and de novo point and large microdeletion mutation in PRRT2‐related epilepsyBrain and Behavior, 2020
- Copy Number Variation2018
- 16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohortAmerican Journal of Medical Genetics Part A, 2016
- PRRT2 Is a Key Component of the Ca2+-Dependent Neurotransmitter Release MachineryCell Reports, 2016
- Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical ComorbiditiesJAMA Psychiatry, 2016
- PRRT2-related disorders: further PKD and ICCA cases and review of the literatureJournal of Neurology, 2013
- Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile ConvulsionsCell Reports, 2012
- PRRT2 Mutations Cause Benign Familial Infantile Epilepsy and Infantile Convulsions with Choreoathetosis SyndromeThe American Journal of Human Genetics, 2012